Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
Irina V. Lyadova, Alexander V. Panteleev
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 262

Showing 1-25 of 262 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 367
Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques
Karin Dijkman, Claudia C. Sombroek, Richard A. W. Vervenne, et al.
Nature Medicine (2019) Vol. 25, Iss. 2, pp. 255-262
Closed Access | Times Cited: 254
Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control
Hannah P. Gideon, Travis K. Hughes, Constantine N. Tzouanas, et al.
Immunity (2022) Vol. 55, Iss. 5, pp. 827-846.e10
Open Access | Times Cited: 180
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Elisa Petruccioli, Thomas J. Scriba, Linda Petrone, et al.
European Respiratory Journal (2016) Vol. 48, Iss. 6, pp. 1751-1763
Open Access | Times Cited: 176
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Tiago Torres, Andrea Chiricozzi, L. Puig, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 333-342
Open Access | Times Cited: 27
Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of Tuberculosis
Ahmed S. Doghish, Ahmed I. Abulsoud, Yara A. Nassar, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 1
Closed Access | Times Cited: 2
Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate
Marcellus Korompis, Cynthia Voss, Shuailin Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection
Hongbo Shen, Zheng W. Chen
Cellular and Molecular Immunology (2017) Vol. 15, Iss. 3, pp. 216-225
Open Access | Times Cited: 142
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
André G. Loxton, Julia K. Knaul, Leander Grode, et al.
Clinical and Vaccine Immunology (2017) Vol. 24, Iss. 2
Open Access | Times Cited: 130
Can we predict tuberculosis cure? What tools are available?
Delia Goletti, Cecilia S. Lindestam Arlehamn, Thomas J. Scriba, et al.
European Respiratory Journal (2018) Vol. 52, Iss. 5, pp. 1801089-1801089
Open Access | Times Cited: 86
Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis
Nargis Khan, Laura Mendonca, Achal Dhariwal, et al.
Mucosal Immunology (2019) Vol. 12, Iss. 3, pp. 772-783
Open Access | Times Cited: 77
Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change
Miguel Nogueira, Richard B. Warren, Tiago Torres
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 4, pp. 824-834
Closed Access | Times Cited: 71
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
Divya Tiwari, Adrian R. Martineau
Seminars in Immunology (2022) Vol. 65, pp. 101672-101672
Open Access | Times Cited: 56
Talaromyces marneffei Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms
Kritsada Pruksaphon, Joshua D. Nosanchuk, Kavi Ratanabanangkoon, et al.
Journal of Fungi (2022) Vol. 8, Iss. 2, pp. 200-200
Open Access | Times Cited: 45
Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes
Sadia Akter, Kuldeep S Chauhan, Micah Dunlap, et al.
Cell Reports (2022) Vol. 39, Iss. 12, pp. 110983-110983
Open Access | Times Cited: 44
IL-17 Production from T Helper 17, Mucosal-Associated Invariant T, and γδ Cells in Tuberculosis Infection and Disease
Felicity J. Coulter, Amy Parrish, Declan Manning, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 72
Th1 cytokines, true functional signatures for protective immunity against TB?
Gucheng Zeng, Guoliang Zhang, Xinchun Chen
Cellular and Molecular Immunology (2017) Vol. 15, Iss. 3, pp. 206-215
Open Access | Times Cited: 70
Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity
Masoud Shamaei, Esmaeil Mortaz, Mihan Pourabdollah, et al.
Human Immunology (2017) Vol. 79, Iss. 1, pp. 63-69
Open Access | Times Cited: 68
<p>Silver Nanoparticles for the Therapy of Tuberculosis</p>
Flaviu Tăbăran, Cristian Matea, Teodora Mocan, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 2231-2258
Open Access | Times Cited: 67
Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases
Bas C. Mourik, Erik Lubberts, Jurriaan E.M. de Steenwinkel, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 66
Yin and yang of interleukin-17 in host immunity to infection
Shibali Das, Shabaana A. Khader
F1000Research (2017) Vol. 6, pp. 741-741
Open Access | Times Cited: 66
The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Osagie A. Eribo, Nelita du Plessis, Mumin Ozturk, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 8, pp. 1497-1509
Open Access | Times Cited: 63
Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic
Ashok Aspatwar, Wenping Gong, Shuyong Wang, et al.
International Reviews of Immunology (2021) Vol. 41, Iss. 2, pp. 283-296
Open Access | Times Cited: 49
Classical CD4 T cells as the cornerstone of antimycobacterial immunity
Jeffrey Morgan, Kaylin Muskat, Rashmi Tippalagama, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 10-29
Open Access | Times Cited: 47
Cytokine storm in tuberculosis and IL-6 involvement
Funmilayo Grâce Boni, Insaf Hamdi, Liadrine Moukendza Koundi, et al.
Infection Genetics and Evolution (2021) Vol. 97, pp. 105166-105166
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top